- Home
- BG vs SNN Comparison
BG vs SNN Comparison
Compare BG & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BG
- SNN
- Stock Information
- Founded
- BG 1818
- SNN 1856
- Country
- BG United States
- SNN United Kingdom
- Employees
- BG N/A
- SNN N/A
- Industry
- BG Packaged Foods
- SNN Industrial Specialties
- Sector
- BG Consumer Staples
- SNN Health Care
- Exchange
- BG Nasdaq
- SNN Nasdaq
- Market Cap
- BG 12.2B
- SNN 11.1B
- IPO Year
- BG N/A
- SNN 1999
- Fundamental
- Price
- BG $73.08
- SNN $26.13
- Analyst Decision
- BG Buy
- SNN Strong Buy
- Analyst Count
- BG 5
- SNN 1
- Target Price
- BG $97.20
- SNN N/A
- AVG Volume (30 Days)
- BG 1.8M
- SNN 567.3K
- Earning Date
- BG 02-05-2025
- SNN 02-25-2025
- Dividend Yield
- BG 3.72%
- SNN 2.87%
- EPS Growth
- BG N/A
- SNN 39.77
- EPS
- BG 7.99
- SNN 0.35
- Revenue
- BG $53,108,000,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- BG $9.79
- SNN $6.16
- Revenue Next Year
- BG $8.03
- SNN $4.65
- P/E Ratio
- BG $9.14
- SNN $37.35
- Revenue Growth
- BG N/A
- SNN 5.48
- 52 Week Low
- BG $67.40
- SNN $23.65
- 52 Week High
- BG $114.92
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- BG 47.29
- SNN 59.89
- Support Level
- BG $69.44
- SNN $25.54
- Resistance Level
- BG $71.59
- SNN $26.09
- Average True Range (ATR)
- BG 2.07
- SNN 0.33
- MACD
- BG 0.34
- SNN 0.06
- Stochastic Oscillator
- BG 67.78
- SNN 95.62
About BG Bunge Limited
Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes, and corn-based products in North and South America.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.